Immunotherapy with Surgery Raises Hopes for Mesothelioma Patients
Researchers believe combining surgery with immunotherapy vaccines may advance mesothelioma treatment.
Researchers believe combining surgery with immunotherapy vaccines may advance mesothelioma treatment.
For Immediate Release: June 17, 2015 Contact: Alex Formuzis, EWG Action Fund: 202.667.6982 or alex@ewg.org Washington, D.C. – The U.S. Environmental Protection Agency’s official guidance on the demolition of crumbling buildings with asbestos is woefully outdated and must be revamped to protect public health, says the agency’s own inspector general in a new report. The EPA’s Office […]
Study finds treatment and survival disparities among blacks and whites diagnosed with mesothelioma.
University of Sydney Medical School professor has developed TargomiRs, a potential new treatment for mesothelioma cancer patients.
University of Sydney Medical School professor has developed TargomiRs, a potential new treatment for mesothelioma cancer patients.
Washington, D.C. – (June 16, 2015) – A man diagnosed with mesothelioma in 2013 saw his tumors virtually disappear within two months of completing an experimental treatment developed by Australian cancer researchers, a newly published study reports. Bradley Selmon, 51, who was exposed to asbestos over years of working as a plumber in Sydney, shared […]
Former employee of ten years at Avondale Shipyard is suing the company for damages from asbestos exposure, which has led to silicosis disease.
Former employee of ten years at Avondale Shipyard is suing the company for damages from asbestos exposure, which has led to silicosis disease.
Ochsner Cancer Institute launches the Mesothelioma Patient Assistance Fund — the first mesothelioma-specific cancer fund in the Southeast.
For Immediate Release: June 10, 2015 Contact: Alex Formuzis, EWG Action Fund: 202.667.6982 or alex@ewg.org Washington, D.C. – For decades, American workers have been breathing air contaminated with asbestos in excess of federal health limits, according to a new analysis of federal government air sampling data. In a study published last month in the journal, Regulatory Toxicology and Pharmacology researchers from […]
A new asbestos teaching facility, research lab, and community resource opened as ULM’s newest multi-use building in Monroe’s Toxicology Department.
A new asbestos teaching facility, research lab, and community resource opened as ULM’s newest multi-use building in Monroe’s Toxicology Department.
Doctors at the 2015 American Society of Clinical Oncology annual meeting suggested adding bevacizumab to traditional chemotherapy regimen for mesothelioma.
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.